Medical Developments International Limited (MVP) Stock Statistics & Valuation Metrics

Medical Developments International Limited has a market cap or net worth of AU$45.63M. The enterprise value is AU$29.27M.

Medical Developments International Limited has 112,658,325 shares outstanding. The number of shares has decreased by -2.65% in one year.

Medical Developments International Limited’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 2.90%.

The current PE Ratio of Medical Developments International Limited is ―. Medical Developments International Limited’s PEG ratio is -6.10.

In the last 12 months, Medical Developments International Limited had revenue of 39.06M and earned 94.00K in profits. Earnings per share was <0.01.

In the last 12 months, operating cash flow was 993.00K and capital expenditures -507.00K, giving a free cash flow of 486.00K billion.

Medical Developments International Limited pays an annual dividend of AU$0.019, resulting in a dividend yield of ―

Medical Developments International Limited upcoming earnings date is Aug 20, 2026, TBA (Confirmed).

Medical Developments International Limited as a current ratio of 4.54, with Debt / Equity ratio of 6.09%

In the past 12 months, Medical Developments International Limited has paid 74.00K in taxes.

Medical Developments International Limited EV to EBITDA ratio is 29.14, with an EV/FCF ratio of -100.37.

Medical Developments International Limited has AU$16.88M in cash and marketable securities with AU$3.34M in debt, giving a net cash position of AU$13.54M billion.

Gross margin is 52.71%, with operating margin of 7.87%, and net profit margin of 0.24%.

The average price target for Medical Developments International Limited is AU$0.85, which is 11.43% higher than the current price. The consensus rating is Moderate Buy